BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 31707632)

  • 1. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
    Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
    Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.
    Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S
    Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse-hamster chimeric prion protein (PrP) devoid of N-terminal residues 23-88 restores susceptibility to 22L prions, but not to RML prions in PrP-knockout mice.
    Uchiyama K; Miyata H; Yano M; Yamaguchi Y; Imamura M; Muramatsu N; Das NR; Chida J; Hara H; Sakaguchi S
    PLoS One; 2014; 9(10):e109737. PubMed ID: 25330286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central residues in prion protein PrP
    Pasiana AD; Miyata H; Chida J; Hara H; Imamura M; Atarashi R; Sakaguchi S
    J Biol Chem; 2022 Sep; 298(9):102381. PubMed ID: 35973512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions.
    Yamaguchi Y; Miyata H; Uchiyama K; Ootsuyama A; Inubushi S; Mori T; Muramatsu N; Katamine S; Sakaguchi S
    PLoS One; 2012; 7(8):e43540. PubMed ID: 22927985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-dependent role of copper in prion disease through binding to histidine residues in the N-terminal domain of prion protein.
    Hara H; Miyata H; Chida J; Sakaguchi S
    J Neurochem; 2023 Nov; 167(3):394-409. PubMed ID: 37777338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.
    Khalifé M; Reine F; Paquet-Fifield S; Castille J; Herzog L; Vilotte M; Moudjou M; Moazami-Goudarzi K; Makhzami S; Passet B; Andréoletti O; Vilette D; Laude H; Béringue V; Vilotte JL
    J Virol; 2016 Feb; 90(3):1638-46. PubMed ID: 26608316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first non-prion pathogen identified: neurotropic influenza virus.
    Sakaguchi S; Hara H
    Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
    Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
    J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB; Geoghegan JC; Supattapone S
    PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein protects mice from lethal infection with influenza A viruses.
    Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
    PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis.
    Mastrangelo P; Westaway D
    Gene; 2001 Sep; 275(1):1-18. PubMed ID: 11574147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
    Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
    J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.